Washington, November 17 (RHC)-- U.S. President Donald Trump has nominated Alex Azar, a former top executive of pharmaceutical giant Eli Lilly, to lead the Department of Health and Human Services. The post has been vacant since the resignation of Tom Price.
Public Citizen’s Robert Weissman criticized the nomination, saying: “Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.”
Donald Trump Nominates Former Drug Company Executive as HHS Secretary
Facebook
Twitter
Pinterest
Telegram
Linkedin
WhatsApp
Matérias relacionadas
Comentários
Deixe um comentário
Todos os campos são requeridos
Mais vistas
- Presidente da Assembleia Nacional destaca vontade política e compromisso de Cuba para seguir em frente
- Filmes da Argentina e do México recebem prêmios Coral no Festival do Cinema Novo Latino-Americano
- ALBA-TCP realiza 24ª Cúpula de Chefes de Estado e de Governo em Caracas
- ALBA-TCP, em defesa do bem-estar e da soberania dos povos
- Ouro para Cuba no campeonato mundial júnior de raquetebol
